ODC vs OCUL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

ODC has stronger fundamentals based on our AI analysis.

ODC
Oil-Dri Corp of America
BUY
77%
Confidence
VS
OCUL
OCULAR THERAPEUTIX, INC
SELL
72%
Confidence

ODC vs OCUL Fundamental Comparison

Metric ODC OCUL
Revenue $238.2M $52.0M
Net Income $28.0M $-265.9M
Net Margin 11.8% -511.9%
ROE 10.3% -40.6%
ROA 7.2% -32.9%
Current Ratio 3.45x 15.39x
Debt/Equity 0.00x 0.04x
EPS $1.69 $-1.42

Green = Better metric | Red = Weaker metric

View Full ODC Analysis →
View Full OCUL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

ODC vs AAPL OCUL vs MSFT ODC vs GOOGL OCUL vs AMZN

ODC vs OCUL: Frequently Asked Questions

Is ODC or OCUL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), ODC has stronger fundamentals. ODC is rated BUY (77% confidence) while OCUL is rated SELL (72% confidence). This is not investment advice.

How does ODC compare to OCUL fundamentally?

Oil-Dri Corp of America has ROE of 10.3% vs OCULAR THERAPEUTIX, INC's -40.6%. Net margins are 11.8% vs -511.9% respectively.

Which stock pays higher dividends, ODC or OCUL?

ODC has a dividend yield of N/A or no dividend while OCUL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ODC or OCUL for long term?

For long-term investing, consider that ODC has BUY rating with 77% confidence, while OCUL has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ODC vs OCUL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ODC vs OCUL, the AI consensus favors ODC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.